A Phase 1, Single-center, Randomized, Double-blind, Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Doses of AVP-786 (Deuterated Dextromethorphan) in Healthy Volunteers

Trial Profile

A Phase 1, Single-center, Randomized, Double-blind, Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Doses of AVP-786 (Deuterated Dextromethorphan) in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Mar 2014

At a glance

  • Drugs Deudextromethorphan (Primary) ; Dextromethorphan/quinidine; Quinidine
  • Indications Major depressive disorder; Neurological disorders; Neuropathic pain; Psychiatric disorders
  • Focus Pharmacokinetics
  • Sponsors Avanir Pharmaceuticals
  • Most Recent Events

    • 28 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Feb 2013 Additional source identified and intergrated (ClinicalTrials.gov NCT01787747).
    • 08 Feb 2013 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top